Part of the Advances in Experimental Medicine and Biology book series (volume 611)
Development of AEZS-115 (ZEN-019) by Optimization of Structurally Unique, Orally Active, Peptidomimetic GnRH Antagonists
KeywordsLuteinizing Hormone Benign Prostate Hyperplasia Precocious Puberty GnRH Antagonist Metabolic Stability
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
The authors would like to thank A. Bork, R. Eckhard, B. Heil, A. Hofmann, E. Jaschob, B. Krönert, T. Kynast, C. Lang, A. Linsner, G. Müller, J. Schumann and K. Zimmermann for excellent technical assistance.
- 2.Armer, R.E., et al., Curr. Med. Chem. 11(22), 3017–3028 (2004).Google Scholar
© Springer Science+Business Media, LLC 2009